Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan D Kilpatrick

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Kidney International|April 21, 2005
Reverse epidemiology of blood pressure in dialysis patientsKamyar Kalantar-Zadeh, Ryan D Kilpatrick, Joel D Kopple
British Journal of Clinical Pharmacology|April 28, 2023
Letter to the editor concerning the article: 'Potential cerebrovascular accident signal for risankizumab: A disproportionality analysis of the FDA adverse event reporting system (FAERS)'Ranjeeta Sinvhal, Whitney S Krueger, Ryan D Kilpatrick, et al.
Blood Purification|January 4, 2005
Reverse epidemiology: a spurious hypothesis or a hardcore reality?Kamyar Kalantar-Zadeh, Ryan D Kilpatrick, Noriko Kuwae, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|September 30, 2005
A matched comparison of serum lipids between hemodialysis patients and nondialysis morbid controlsKamyar Kalantar-Zadeh, Ryan D Kilpatrick, Joel D Kopple, et al.
Advances in Chronic Kidney Disease|February 28, 2012
Confounding and control of confounding in nonexperimental studies of medications in patients with CKDBrian D Bradbury, David T Gilbertson, M Alan Brookhart, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 21, 2013
CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysisGeoffrey A Block, Ryan D Kilpatrick, Kimberly A Lowe, et al.
Hypertension (Dallas, Tex. : 1979)|February 9, 2005
Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessionsKamyar Kalantar-Zadeh, Ryan D Kilpatrick, Charles J McAllister, et al.
The American Journal of Clinical Nutrition|March 10, 2005
Survival advantages of obesity in dialysis patientsKamyar Kalantar-Zadeh, Kevin C Abbott, Abdulla K Salahudeen, et al.
JID Innovations : Skin Science From Molecules to Population Health|March 6, 2023
Impact of Season and Other Factors on Initiation, Discontinuation, and Switching of Systemic Drug Therapy in Patients with Psoriasis: A Retrospective StudyHuifang Liang, Brenna Kirk, Jennifer M Polinski, et al.
Pharmacoepidemiology and Drug Safety|July 8, 2011
The association of vitamin D use with hypercalcemia and hyperphosphatemia in hemodialysis patients: a case-crossover studyRyan D Kilpatrick, Mark D Danese, Vasily Belozeroff, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Kidney International|April 21, 2005
Reverse epidemiology of blood pressure in dialysis patientsKamyar Kalantar-Zadeh, Ryan D Kilpatrick, Joel D Kopple
British Journal of Clinical Pharmacology|April 28, 2023
Letter to the editor concerning the article: 'Potential cerebrovascular accident signal for risankizumab: A disproportionality analysis of the FDA adverse event reporting system (FAERS)'Ranjeeta Sinvhal, Whitney S Krueger, Ryan D Kilpatrick, et al.
Blood Purification|January 4, 2005
Reverse epidemiology: a spurious hypothesis or a hardcore reality?Kamyar Kalantar-Zadeh, Ryan D Kilpatrick, Noriko Kuwae, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|September 30, 2005
A matched comparison of serum lipids between hemodialysis patients and nondialysis morbid controlsKamyar Kalantar-Zadeh, Ryan D Kilpatrick, Joel D Kopple, et al.
Advances in Chronic Kidney Disease|February 28, 2012
Confounding and control of confounding in nonexperimental studies of medications in patients with CKDBrian D Bradbury, David T Gilbertson, M Alan Brookhart, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 21, 2013
CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysisGeoffrey A Block, Ryan D Kilpatrick, Kimberly A Lowe, et al.
Hypertension (Dallas, Tex. : 1979)|February 9, 2005
Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessionsKamyar Kalantar-Zadeh, Ryan D Kilpatrick, Charles J McAllister, et al.
The American Journal of Clinical Nutrition|March 10, 2005
Survival advantages of obesity in dialysis patientsKamyar Kalantar-Zadeh, Kevin C Abbott, Abdulla K Salahudeen, et al.
JID Innovations : Skin Science From Molecules to Population Health|March 6, 2023
Impact of Season and Other Factors on Initiation, Discontinuation, and Switching of Systemic Drug Therapy in Patients with Psoriasis: A Retrospective StudyHuifang Liang, Brenna Kirk, Jennifer M Polinski, et al.
Pharmacoepidemiology and Drug Safety|July 8, 2011
The association of vitamin D use with hypercalcemia and hyperphosphatemia in hemodialysis patients: a case-crossover studyRyan D Kilpatrick, Mark D Danese, Vasily Belozeroff, et al.
Pageof 5